Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.

B Correction to: Cancer Immunology, Immunotherapy b https://doi.org/10.1007/s00262-022-03318-x In the online published article, the affiliation details for Authors Tianyun Qiao, Yangbo Feng and Yong Han were given as: Department of Thoracic Surgery, Air Force Specialty Medical Center, Fourth Military Medical University, Xi'an 710032, China but should have been Department of Thoracic Surgery, Air Force Medical Center, Beijing 100142, China Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Tianyun Qiao, Jinbo Zhao and Xiangbing Xin have contributed equally to this work. [Extracted from the article]